SEC Form 4 · accession 0000899243-16-023203
Inhibitor Therapeutics, Inc. · INTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Francis E Odonnell Jr.
Officer — Executive Chairman · Director
Period of report
Jun 15, 2016
Accepted (ET)
Jun 17, 2016 · 5:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001042418
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.0001 par value per shareF1,F2 | Jun 15, 2016 | S$0 | 2,560,000 | — | D | 11,440,000 | I | By Hopkins Capital Group II, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On June 15, 2016, Hopkins Capital Group II, LLC ("HCGII") transferred 2,560,000 shares of common stock in satisfaction of $192,000 in then outstanding debt to an unrelated member HCGII who is not an affiliate of the issuer.
- F2The shares are owned by HCGII. The Reporting Person is a discretionary beneficiary of an irrevocable spendthrift trust which directly owns a minority membership interest in HCGII. The Reporting Person disclaims ownership of all securities held by HCGII.